Overview

Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer

Status:
Completed
Trial end date:
2018-10-18
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to help answer the following research question: whether enzastaurin given together with fulvestrant can help participants who have breast cancer and make the tumor smaller or disappear and for how long.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Estradiol
Fulvestrant